Ginkgo Bioworks Holdings DNA
NYSE DNA
$11.52 -0.24 (-2.00%)
As of: Oct 14, 2026 · 3:59 PM EDT

Ginkgo Bioworks Holdings (DNA) Notes Payables (2020)

Updated

Ginkgo Bioworks Holdings (DNA) reported Notes Payables of $300,000 for Q4 2020.

Analysis

Ginkgo Bioworks Holdings (DNA) Notes Payables (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 43.58 Bn 35.28 Bn 1.44 Bn
2 Medpace Holdings 17.39 Bn 15.45 Bn 201.64 Mn
3 Charles River Laboratories International 14.59 Bn 13.78 Bn 363.37 Mn
4 Icon 13.27 Bn 10.38 Bn 479.29 Mn
5 Fortrea Holdings 2.03 Bn 1.41 Bn 139.20 Mn
6 Ginkgo Bioworks Holdings 716.57 Mn -45.52 Mn 18.44 Mn
7 Evotec SE 506.10 Mn -1.10 Bn -
8 Champions Oncology 66.85 Mn 41.93 Mn 7.70 Mn
9 MindWalk Holdings 63.92 Mn 27.58 Mn 1.61 Mn
10 Natural Alternatives International 6.75 Mn -21.33 Mn 1.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 300,000.00
API Access

Ginkgo Bioworks Holdings Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=DNA&period=max&api_key=YOUR_API_KEY